Partner News | Published: Tuesday, March 3, 2026
MedAxiom, the cardiovascular community’s premier source for organizational performance solutions, announced an industry partnership with Positron Corporation, a medical technology company focused on advancing cardiac positron emission tomography (PET) and PET/computed tomography (PET/CT) imaging.
Through this partnership, Positron will engage with the MedAxiom community to support cardiology programs seeking to expand or optimize cardiac PET imaging. Positron co-develops, manufactures, and sells advanced PET and PET-CT imaging systems and provides comprehensive clinical services to nuclear medicine healthcare providers across North America. Specializing in cardiac Positron Emission Tomography (PET) imaging, Positron’s mission is to deliver innovative, cost-effective imaging solutions that improve patient care and outcomes. “Cardiac PET continues to play an important role in the diagnosis and management of coronary artery disease, ischemia, and heart failure, and access to reliable technology and operational expertise is essential for successful program development,” said Joe Sasson, PhD, executive vice president of Ventures and chief commercial officer at MedAxiom. “Positron brings deep experience in cardiac PET imaging, along with practical insight into implementation, workflow and ongoing support. Their knowledge will be a valuable resource for MedAxiom members as they evaluate imaging strategies and work to deliver high-quality, efficient cardiovascular care.”
Positron’s cardiac PET and PET/CT systems are designed to support diagnostic accuracy, operational reliability, and flexible adoption for practices of varying sizes. In addition to imaging technology, the company offers end-to-end services spanning system implementation, staff training, and ongoing technical and clinical support to help practices integrate cardiac PET into routine care.
“MedAxiom is a trusted leader in cardiovascular excellence, and we are proud to join such a valuable network,” said Adel Abdullah, president of Positron. “This partnership connects Positron with a community at the forefront of advancing cardiovascular care through the PET modality. MedAxiom will be an important resource as we work with cardiology practices to expand access to cardiac PET imaging and support the continued adoption of these technologies.”
By collaborating with MedAxiom, Positron aims to support cardiology leaders with education, operational insight and practical guidance related to cardiac PET imaging programs, helping practices align diagnostic capabilities with evolving clinical and economic demands.
About MedAxiom
MedAxiom, an American College of Cardiology Company, is the cardiovascular community’s premier source for organizational performance solutions. By combining the knowledge and power of hundreds of cardiovascular organizations, thousands of clinicians and administrators, and dozens of industry partners, MedAxiom helps transform cardiovascular care. Learn more at medaxiom.com.
About Positron Corporation
Positron Corporation is a medical technology company that co-develops, manufactures, and sells PET and PET/CT imaging systems, along with comprehensive clinical services for nuclear medicine and cardiology providers across North America. Positron focuses on advancing cardiac PET imaging by supporting diagnostic accuracy, operational efficiency, and accessible adoption of molecular imaging technologies. Learn more at positron.com.
By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.
